Cabot Corporation Stock News

Cabot Corp announces Reinforcement Materials segment executive transition. Announces Bill Masterson as SVP and President, Reinforcement Materials segment.

Cabot Corp.'s LITX® 95F conductive carbon for use in lithium-ion batteries for energy storage systems named one of the “Top 10 Exhibits of 2025” at CIIE.

BOSTON, Nov. 13, 2025 (GLOBE NEWSWIRE) -- On Thursday, November 13, 2025, the Board of Directors of Cabot Corporation (NYSE: CBT) declared a quarterly dividend of $0.45 per share on all outstanding shares of the Corporation's common stock. The dividend is payable on December 12, 2025, to stockholders of record at the close of business on November 28, 2025.

Cabot (CBT) hasn't been in the spotlight lately, but its current setup may warrant a closer look. The specialty chemicals company has quietly built a strong financial base while its stock remains meaningfully discounted from recent highs.

Cabot Corporation ( CBT ) Q4 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Steven Delahunt - VP of Investor Relations & Treasurer Sean Keohane - President, CEO & Director Erica McLaughlin - Executive VP, CFO & Head of Corporate Strategy Conference Call Participants John Ezekiel Roberts - Mizuho Securities USA LLC, Research Division Emily Fusco - Deutsche Bank AG, Research...

Fourth Quarter 2025 Diluted earnings per share (“EPS”) of $0.79 and Adjusted EPS of $1.70 Fiscal Year 2025 Diluted EPS of $6.02 and Adjusted EPS of $7.25 BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced results for its fourth quarter and fiscal year 2025. Fiscal Year Highlights Fiscal year Diluted EPS of $6.02 and Adjusted EPS of $7.25, which represents a ...

BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced that Robert Rist has been appointed Vice President of Investor Relations and Corporate Planning. The transition will take place over the course of the first quarter of fiscal year 2026.

Cabot Corporation is a fundamentally strong, conservatively managed chemical company trading at a significant discount to fair value. CBT offers high single-digit growth, a well-covered dividend, and is positioned for long-term upside despite recent market-driven declines. Recent results show resilience in key segments and strategic expansion, with risks mainly tied to macro volatility and mark...